Literature DB >> 15180726

Mucosal concentrations of proinflammatory cytokines and chemokines at gastric cardia: implication of Helicobacter pylori infection and gastroesophageal reflux.

Hajime Isomoto1, Yoshito Nishi, Aiping Wang, Fuminao Takeshima, Katsuhisa Omagari, Yohei Mizuta, Saburo Shikuwa, Ikuo Murata, Shigeru Kohno.   

Abstract

OBJECTIVES: The pathogenesis of carditis remains unclear, although gastroesophageal reflux disease (GERD) and Helicobacter pylori infection have been proposed. Little is known about the profile of proinflammatory cytokines and chemokines in the pathogenesis of carditis.
METHODS: We studied 28 patients with GERD and 40 controls. Two biopsy specimens were taken endoscopically from the cardiac mucosa within 5 mm from the squamocolumnar junction; one was snap frozen for measurement of mucosal levels of interleukin 1beta (IL-1beta), tumor necrosis factor-alpha, IL-6, IL-8, monocyte chemoattractant protein 1 (MCP-1), regulated on activation normal T-cell expressed and presumably secreted (RANTES) by enzyme-linked immunosorbent assays, while another was processed for histopathology. H. pylori infection was assessed by serology, rapid urease test, and histology with Giemsa staining. Samples were taken from the cardia of 18 H. pylori-positive patients, before and after eradication treatment.
RESULTS: Carditis was significantly associated with H. pylori infection, but not GERD. IL-8, MCP-1, and RANTES levels were significantly higher in cardiac mucosa of patients with carditis than in those without it and in patients with than without H. pylori infection. IL-8 concentrations were significantly associated with the degree of neutrophil infiltration within the cardiac mucosa and decreased after cure of the infection. Mucosal MCP-1 and RANTES levels correlated positively with the grades of mononuclear cell infiltration and IL-1beta concentrations.
CONCLUSION: Our results indicate that chemokines produced locally in the cardiac mucosa may be involved in the development of H. pylori-associated carditis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15180726     DOI: 10.1111/j.1572-0241.2004.30847.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  11 in total

Review 1.  Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis.

Authors:  Florian Rieder; Piero Biancani; Karen Harnett; Lisa Yerian; Gary W Falk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-18       Impact factor: 4.052

Review 2.  Esophagitis unrelated to reflux disease: current status and emerging diagnostic challenges.

Authors:  Melanie E Johncilla; Amitabh Srivastava
Journal:  Virchows Arch       Date:  2017-10-15       Impact factor: 4.064

3.  Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis.

Authors:  Javier Molina-Infante; Albert J Bredenoord; Edaire Cheng; Evan S Dellon; Glenn T Furuta; Sandeep K Gupta; Ikuo Hirano; David A Katzka; Fouad J Moawad; Marc E Rothenberg; Alain Schoepfer; Stuart J Spechler; Ting Wen; Alex Straumann; Alfredo J Lucendo
Journal:  Gut       Date:  2015-12-18       Impact factor: 23.059

4.  The functional polymorphism in monocyte chemoattractant protein-1 gene increases susceptibility to gastric cancer.

Authors:  Haijuan Gu; Meixin Ni; Xiaohong Guo; Ping Feng; Yanyan Xu; Xiang Gu; Li Yang; Bin Wang
Journal:  Med Oncol       Date:  2010-11-24       Impact factor: 3.064

5.  Critical role of Helicobacter pylori in the pattern of gastritis and carditis in residents of an area with high prevalence of gastric cardia cancer.

Authors:  Masoud Sotoudeh; Mohammad H Derakhshan; Behnoosh Abedi-Ardakani; Mehdi Nouraie; Abass Yazdanbod; Seyyed Mohammad Tavangar; Javad Mikaeli; Shahin Merat; Reza Malekzadeh
Journal:  Dig Dis Sci       Date:  2007-05-10       Impact factor: 3.199

6.  Chronic mucosal inflammation of the gastric cardia in gastroesophageal reflux disease is not regulated by FOXP3-expressing T cells.

Authors:  Arne Kandulski; Thomas Wex; Doerthe Kuester; Klaus Mönkemüller; Ulrich Peitz; Albert Roessner; Peter Malfertheiner
Journal:  Dig Dis Sci       Date:  2009-02-26       Impact factor: 3.199

7.  Effect of lycopene against gastroesophageal reflux disease in experimental animals.

Authors:  Arvind Kumar Giri; Jitendra Kumar Rawat; Manjari Singh; Swetlana Gautam; Gaurav Kaithwas
Journal:  BMC Complement Altern Med       Date:  2015-04-09       Impact factor: 3.659

8.  GEC-derived SFRP5 inhibits Wnt5a-induced macrophage chemotaxis and activation.

Authors:  Chenghai Zhao; Xianmin Bu; Wei Wang; Tingxian Ma; Haiying Ma
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

Review 9.  Esophageal Tumor Microenvironment.

Authors:  Henrik Nienhüser; Naita Wirsik; Thomas Schmidt
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

10.  Immune and Inflammatory Responses in GERD and Lansoprazole.

Authors:  Hajime Isomoto; Yoshito Nishi; Yusei Kanazawa; Saburo Shikuwa; Yohei Mizuta; Kenichiro Inoue; Shigeru Kohno
Journal:  J Clin Biochem Nutr       Date:  2007-09       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.